Please read and agree to the terms and conditions of this site.
@techcrunch.com 2 years ago
Injectsense collects $1.7M grant for its eye implant smaller than a grain of rice
@xconomy.com 3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@techcrunch.com 4 years ago
What top VCs look for in women’s fertility startups
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com 5 years ago
RDMD attacks rare diseases with data mined from health records
@xconomy.com 5 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
@techcrunch.com 6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
@Primary_Immune 6 years ago
On #RareDisease Research & '#GeneTherapy 2.0' - 'We Need To Celebrate Advances in Medical Science – Though They May Take Years to Emerge" https://www.theguardian.com/science/2017/dec/17/stunning-gene-therapy-breakthrough-riposte-to-truth-tarnished-times #OpenScience #science #ITRTG #BigData #genomics #biotech #data #biotech #genetics #innovation #SNRTG #technology